Camila Pauli

Ms. Camila Pauli

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
JLJana Luecht
Jana Luecht
CPCamila Pauli
Camila Pauli
RSRaphael Seiler
Raphael Seiler
AHAlexa-Leona Herre
Alexa-Leona Herre
LBLiliya Brankova
Liliya Brankova
GTGiang Tong
Giang Tong
Congenital heart defects (CHDs) are one of the most common congenital malformations and often require heart surgery with cardiopulmonary bypass (CPB). Children undergoing cardiac surgery with CPB are especially at greater risk of post-operative complications due to a systemic inflammatory response caused by innate inflammatory mediators. However, the pathophysiological response is not fully understood and warrants further investigation. Therefore, we investigated the inflammatory response in macrophages initiated by peri-operative serum samples obtained from patients with CHD undergoing CPB cardiac surgery. Human differentiated THP-1 macrophages were pretreated with Stattic, a STAT3 (Tyr705) inhibitor, before stimulation with serum samples. STAT3 and NF-κB activation were investigated via a Western blot, IL-1β, TNFα, IL-10, mediators for vascular permeability (VEGF-A, ICAM), and SOCS3 gene expressions via RT-qPCR. CPB induced an inflammatory response in macrophages via the activation of the STAT3 but not NF-κB signaling pathway. Longer duration on the CPB correlated with increased cytokine, VEGF, and ICAM expressions, relative to individual pre-operation levels. Patients that did not require CPB showed no significant immune response. Pretreatment with Stattic significantly attenuated all inflammatory mediators investigated except for TNFα in the macrophages. CPB induces an increased expression of cytokines and mediators of vascular permeability via the activation of STAT3 by IL-6 and IL-8 in the serum samples. Stattic attenuates all mediators investigated but promotes TNFα expression.

13 May 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
GTGiang Tong
Giang Tong
JFJohanna Martha Fross
Johanna Martha Fross
JLJanna Luecht
Janna Luecht
CPCamila Pauli
Camila Pauli
LKLukas Maximilian Kautzsch
Lukas Maximilian Kautzsch
KSKatharina R.L. Schmitt
Katharina R.L. Schmitt
Extracellular cold-inducible RNA-binding protein (eCIRBP) is a key driver of sterile inflammation following ischemia/reperfusion (I/R) injury, such as during cardiac surgery. While eCIRBP’s interaction with the TLR4/MD2 complex is known to activate the NF-κB pathway, its role in activating the JAK/STAT3 pathway via the IL-6 receptor is less understood. To investigate this, human THP-1-derived macrophage-like cells were stimulated with a recombinant human active CIRBP peptide (rhCIRBP) with or without Stattic pre-treatment, a selective STAT3 phosphorylation (Y705) inhibitor. Activation of IκBα/NF-κB and JAK/STAT3 was assessed by Western blotting, while gene expressions of inflammatory markers were measured via RT-qPCR. LPS stimulation significantly induced all inflammatory targets investigated (IL-6, IL-1β, TNF-α, MCP-1, ICAM, and SOCS3), while rhCIRBP only significantly induced IL-1β, TNF-α, and ICAM in the THP-1 macrophages. Interestingly, Stattic inactivated both STAT3 and NF-κB pathways, thus resulting in the attenuation of all induced inflammatory responses observed. Our findings confirm eCIRBP as a potent inflammatory mediator, corresponding with reported elevated concentrations of circulatory eCIRBP in patients after cardiac surgery and those suffering from hemorrhagic shock and sepsis. Additionally, we also highlight the crosstalk between the STAT3/ NF-κB pathways that may offer a novel therapeutic strategy for managing both sterile and non-sterile inflammation.